NASH治療薬のパイプラインのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global NASH Drug Pipeline Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16251 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

NASH治療薬のパイプライン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のNASH治療薬のパイプラインの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のNASH治療薬のパイプラインの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 NASH治療薬のパイプライン市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・プロテアーゼ阻害剤、免疫調節剤、マルチキナーゼ阻害剤 用途別セグメントは次のように区分されます。 ・臨床、学術研究 世界のNASH治療薬のパイプライン市場の主要な市場プレーヤーは以下のとおりです。 ・Intercept、Genfit、Allergan、Madrigal、Immuron、Galectin、Gilead、89bio Inc、ABIONYX Pharma SA、Abivax SA、Abliva AB、Acquist Therapeutics、AdAlta Ltd、Afimmune Biopharma Ltd、Zhejiang Doer Biologics Corp、Dicerna Pharmaceuticals Inc、ChemomAb Ltd、DURECT Corp、Eli Lilly and Co、Enanta Pharmaceuticals Inc、EncuraGen Inc、Engitix Ltd、Heprotech Inc、Hinova Pharmaceuticals Inc、HK inno.N Corp、HotSpot Therapeutics Inc 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、NASH治療薬のパイプライン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なNASH治療薬のパイプラインメーカーの企業概要、2019年～2021年までのNASH治療薬のパイプラインの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なNASH治療薬のパイプラインメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別NASH治療薬のパイプラインの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのNASH治療薬のパイプラインの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのNASH治療薬のパイプライン市場予測を収録しています。 ・第12、13、14章では、NASH治療薬のパイプラインの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Intercept、Genfit、Allergan、Madrigal、Immuron、Galectin、Gilead、89bio Inc、ABIONYX Pharma SA、Abivax SA、Abliva AB、Acquist Therapeutics、AdAlta Ltd、Afimmune Biopharma Ltd、Zhejiang Doer Biologics Corp、Dicerna Pharmaceuticals Inc、ChemomAb Ltd、DURECT Corp、Eli Lilly and Co、Enanta Pharmaceuticals Inc、EncuraGen Inc、Engitix Ltd、Heprotech Inc、Hinova Pharmaceuticals Inc、HK inno.N Corp、HotSpot Therapeutics Inc ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：プロテアーゼ阻害剤、免疫調節剤、マルチキナーゼ阻害剤 ・用途別分析2016年-2026年：臨床、学術研究 ・NASH治療薬のパイプラインの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・NASH治療薬のパイプラインのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・NASH治療薬のパイプラインのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・NASH治療薬のパイプラインの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・NASH治療薬のパイプラインの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The NASH Drug Pipeline market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global NASH Drug Pipeline size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global NASH Drug Pipeline market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
NASH Drug Pipeline market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Protease Inhibitor
Immunomodulatory
Multiple Kinase Inhibitor

Market segment by Application can be divided into
Clinical
Academic Research

The key market players for global NASH Drug Pipeline market are listed below:
Intercept
Genfit
Allergan
Madrigal
Immuron
Galectin
Gilead
89bio Inc
ABIONYX Pharma SA
Abivax SA
Abliva AB
Acquist Therapeutics
AdAlta Ltd
Afimmune Biopharma Ltd
Zhejiang Doer Biologics Corp
Dicerna Pharmaceuticals Inc
ChemomAb Ltd
DURECT Corp
Eli Lilly and Co
Enanta Pharmaceuticals Inc
EncuraGen Inc
Engitix Ltd
Heprotech Inc
Hinova Pharmaceuticals Inc
HK inno.N Corp
HotSpot Therapeutics Inc

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe NASH Drug Pipeline product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of NASH Drug Pipeline, with price, sales, revenue and global market share of NASH Drug Pipeline from 2019 to 2021.
Chapter 3, the NASH Drug Pipeline competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the NASH Drug Pipeline breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and NASH Drug Pipeline market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe NASH Drug Pipeline sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 NASH Drug Pipeline Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global NASH Drug Pipeline Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Protease Inhibitor
1.2.3 Immunomodulatory
1.2.4 Multiple Kinase Inhibitor
1.3 Market Analysis by Application
1.3.1 Overview: Global NASH Drug Pipeline Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Clinical
1.3.3 Academic Research
1.4 Global NASH Drug Pipeline Market Size & Forecast
1.4.1 Global NASH Drug Pipeline Sales in Value (2016-2026))
1.4.2 Global NASH Drug Pipeline Sales in Volume (2016-2026)
1.4.3 Global NASH Drug Pipeline Price by Type (2016-2026) & (US$/Unit)
1.5 Global NASH Drug Pipeline Production Capacity Analysis
1.5.1 Global NASH Drug Pipeline Total Production Capacity (2016-2026)
1.5.2 Global NASH Drug Pipeline Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 NASH Drug Pipeline Market Drivers
1.6.2 NASH Drug Pipeline Market Restraints
1.6.3 NASH Drug Pipeline Trends Analysis
2 Manufacturers Profiles
2.1 Intercept
2.1.1 Intercept Details
2.1.2 Intercept Major Business
2.1.3 Intercept NASH Drug Pipeline Product and Services
2.1.4 Intercept NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Genfit
2.2.1 Genfit Details
2.2.2 Genfit Major Business
2.2.3 Genfit NASH Drug Pipeline Product and Services
2.2.4 Genfit NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business
2.3.3 Allergan NASH Drug Pipeline Product and Services
2.3.4 Allergan NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Madrigal
2.4.1 Madrigal Details
2.4.2 Madrigal Major Business
2.4.3 Madrigal NASH Drug Pipeline Product and Services
2.4.4 Madrigal NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Immuron
2.5.1 Immuron Details
2.5.2 Immuron Major Business
2.5.3 Immuron NASH Drug Pipeline Product and Services
2.5.4 Immuron NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Galectin
2.6.1 Galectin Details
2.6.2 Galectin Major Business
2.6.3 Galectin NASH Drug Pipeline Product and Services
2.6.4 Galectin NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Gilead
2.7.1 Gilead Details
2.7.2 Gilead Major Business
2.7.3 Gilead NASH Drug Pipeline Product and Services
2.7.4 Gilead NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 89bio Inc
2.8.1 89bio Inc Details
2.8.2 89bio Inc Major Business
2.8.3 89bio Inc NASH Drug Pipeline Product and Services
2.8.4 89bio Inc NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 ABIONYX Pharma SA
2.9.1 ABIONYX Pharma SA Details
2.9.2 ABIONYX Pharma SA Major Business
2.9.3 ABIONYX Pharma SA NASH Drug Pipeline Product and Services
2.9.4 ABIONYX Pharma SA NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Abivax SA
2.10.1 Abivax SA Details
2.10.2 Abivax SA Major Business
2.10.3 Abivax SA NASH Drug Pipeline Product and Services
2.10.4 Abivax SA NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Abliva AB
2.11.1 Abliva AB Details
2.11.2 Abliva AB Major Business
2.11.3 Abliva AB NASH Drug Pipeline Product and Services
2.11.4 Abliva AB NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Acquist Therapeutics
2.12.1 Acquist Therapeutics Details
2.12.2 Acquist Therapeutics Major Business
2.12.3 Acquist Therapeutics NASH Drug Pipeline Product and Services
2.12.4 Acquist Therapeutics NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 AdAlta Ltd
2.13.1 AdAlta Ltd Details
2.13.2 AdAlta Ltd Major Business
2.13.3 AdAlta Ltd NASH Drug Pipeline Product and Services
2.13.4 AdAlta Ltd NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Afimmune Biopharma Ltd
2.14.1 Afimmune Biopharma Ltd Details
2.14.2 Afimmune Biopharma Ltd Major Business
2.14.3 Afimmune Biopharma Ltd NASH Drug Pipeline Product and Services
2.14.4 Afimmune Biopharma Ltd NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Zhejiang Doer Biologics Corp
2.15.1 Zhejiang Doer Biologics Corp Details
2.15.2 Zhejiang Doer Biologics Corp Major Business
2.15.3 Zhejiang Doer Biologics Corp NASH Drug Pipeline Product and Services
2.15.4 Zhejiang Doer Biologics Corp NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Dicerna Pharmaceuticals Inc
2.16.1 Dicerna Pharmaceuticals Inc Details
2.16.2 Dicerna Pharmaceuticals Inc Major Business
2.16.3 Dicerna Pharmaceuticals Inc NASH Drug Pipeline Product and Services
2.16.4 Dicerna Pharmaceuticals Inc NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 ChemomAb Ltd
2.17.1 ChemomAb Ltd Details
2.17.2 ChemomAb Ltd Major Business
2.17.3 ChemomAb Ltd NASH Drug Pipeline Product and Services
2.17.4 ChemomAb Ltd NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 DURECT Corp
2.18.1 DURECT Corp Details
2.18.2 DURECT Corp Major Business
2.18.3 DURECT Corp NASH Drug Pipeline Product and Services
2.18.4 DURECT Corp NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Eli Lilly and Co
2.19.1 Eli Lilly and Co Details
2.19.2 Eli Lilly and Co Major Business
2.19.3 Eli Lilly and Co NASH Drug Pipeline Product and Services
2.19.4 Eli Lilly and Co NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Enanta Pharmaceuticals Inc
2.20.1 Enanta Pharmaceuticals Inc Details
2.20.2 Enanta Pharmaceuticals Inc Major Business
2.20.3 Enanta Pharmaceuticals Inc NASH Drug Pipeline Product and Services
2.20.4 Enanta Pharmaceuticals Inc NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 EncuraGen Inc
2.21.1 EncuraGen Inc Details
2.21.2 EncuraGen Inc Major Business
2.21.3 EncuraGen Inc NASH Drug Pipeline Product and Services
2.21.4 EncuraGen Inc NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 Engitix Ltd
2.22.1 Engitix Ltd Details
2.22.2 Engitix Ltd Major Business
2.22.3 Engitix Ltd NASH Drug Pipeline Product and Services
2.22.4 Engitix Ltd NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.23 Heprotech Inc
2.23.1 Heprotech Inc Details
2.23.2 Heprotech Inc Major Business
2.23.3 Heprotech Inc NASH Drug Pipeline Product and Services
2.23.4 Heprotech Inc NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.24 Hinova Pharmaceuticals Inc
2.24.1 Hinova Pharmaceuticals Inc Details
2.24.2 Hinova Pharmaceuticals Inc Major Business
2.24.3 Hinova Pharmaceuticals Inc NASH Drug Pipeline Product and Services
2.24.4 Hinova Pharmaceuticals Inc NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.25 HK inno.N Corp
2.25.1 HK inno.N Corp Details
2.25.2 HK inno.N Corp Major Business
2.25.3 HK inno.N Corp NASH Drug Pipeline Product and Services
2.25.4 HK inno.N Corp NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.26 HotSpot Therapeutics Inc
2.26.1 HotSpot Therapeutics Inc Details
2.26.2 HotSpot Therapeutics Inc Major Business
2.26.3 HotSpot Therapeutics Inc NASH Drug Pipeline Product and Services
2.26.4 HotSpot Therapeutics Inc NASH Drug Pipeline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 NASH Drug Pipeline Sales by Manufacturer
3.1 Global NASH Drug Pipeline Sales in Volume by Manufacturer (2019-2021e)
3.2 Global NASH Drug Pipeline Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in NASH Drug Pipeline
3.4 Market Concentration Rate
3.4.1 Top 3 NASH Drug Pipeline Manufacturer Market Share
3.4.2 Top 6 NASH Drug Pipeline Manufacturer Market Share
3.5 Global NASH Drug Pipeline Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and NASH Drug Pipeline Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global NASH Drug Pipeline Market Size by Region
4.1.1 Global NASH Drug Pipeline Sales in Volume by Region (2016-2026)
4.1.2 Global NASH Drug Pipeline Revenue by Region (2016-2026)
4.2 North America NASH Drug Pipeline Revenue (2016-2026)
4.3 Europe NASH Drug Pipeline Revenue (2016-2026)
4.4 Asia-Pacific NASH Drug Pipeline Revenue (2016-2026)
4.5 South America NASH Drug Pipeline Revenue (2016-2026)
4.6 Middle East and Africa NASH Drug Pipeline Revenue (2016-2026)
5 Market Segment by Type
5.1 Global NASH Drug Pipeline Sales in Volume by Type (2016-2026)
5.2 Global NASH Drug Pipeline Revenue by Type (2016-2026)
5.3 Global NASH Drug Pipeline Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global NASH Drug Pipeline Sales in Volume by Application (2016-2026)
6.2 Global NASH Drug Pipeline Revenue by Application (2016-2026)
6.3 Global NASH Drug Pipeline Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America NASH Drug Pipeline Sales by Type (2016-2026)
7.2 North America NASH Drug Pipeline Sales by Application (2016-2026)
7.3 North America NASH Drug Pipeline Market Size by Country
7.3.1 North America NASH Drug Pipeline Sales in Volume by Country (2016-2026)
7.3.2 North America NASH Drug Pipeline Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe NASH Drug Pipeline Sales by Type (2016-2026)
8.2 Europe NASH Drug Pipeline Sales by Application (2016-2026)
8.3 Europe NASH Drug Pipeline Market Size by Country
8.3.1 Europe NASH Drug Pipeline Sales in Volume by Country (2016-2026)
8.3.2 Europe NASH Drug Pipeline Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific NASH Drug Pipeline Sales by Type (2016-2026)
9.2 Asia-Pacific NASH Drug Pipeline Sales by Application (2016-2026)
9.3 Asia-Pacific NASH Drug Pipeline Market Size by Region
9.3.1 Asia-Pacific NASH Drug Pipeline Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific NASH Drug Pipeline Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America NASH Drug Pipeline Sales by Type (2016-2026)
10.2 South America NASH Drug Pipeline Sales by Application (2016-2026)
10.3 South America NASH Drug Pipeline Market Size by Country
10.3.1 South America NASH Drug Pipeline Sales in Volume by Country (2016-2026)
10.3.2 South America NASH Drug Pipeline Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa NASH Drug Pipeline Sales by Type (2016-2026)
11.2 Middle East & Africa NASH Drug Pipeline Sales by Application (2016-2026)
11.3 Middle East & Africa NASH Drug Pipeline Market Size by Country
11.3.1 Middle East & Africa NASH Drug Pipeline Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa NASH Drug Pipeline Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 NASH Drug Pipeline Typical Distributors
12.3 NASH Drug Pipeline Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global NASH Drug Pipeline Revenue by Type, (USD Million), 2021-2026
Table 2. Global NASH Drug Pipeline Revenue by Application, (USD Million), 2021-2026
Table 3. Intercept Basic Information, Manufacturing Base and Competitors
Table 4. Intercept Major Business
Table 5. Intercept NASH Drug Pipeline Product and Services
Table 6. Intercept NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Genfit Basic Information, Manufacturing Base and Competitors
Table 8. Genfit Major Business
Table 9. Genfit NASH Drug Pipeline Product and Services
Table 10. Genfit NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Allergan Basic Information, Manufacturing Base and Competitors
Table 12. Allergan Major Business
Table 13. Allergan NASH Drug Pipeline Product and Services
Table 14. Allergan NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Madrigal Basic Information, Manufacturing Base and Competitors
Table 16. Madrigal Major Business
Table 17. Madrigal NASH Drug Pipeline Product and Services
Table 18. Madrigal NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Immuron Basic Information, Manufacturing Base and Competitors
Table 20. Immuron Major Business
Table 21. Immuron NASH Drug Pipeline Product and Services
Table 22. Immuron NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Galectin Basic Information, Manufacturing Base and Competitors
Table 24. Galectin Major Business
Table 25. Galectin NASH Drug Pipeline Product and Services
Table 26. Galectin NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Gilead Basic Information, Manufacturing Base and Competitors
Table 28. Gilead Major Business
Table 29. Gilead NASH Drug Pipeline Product and Services
Table 30. Gilead NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. 89bio Inc Basic Information, Manufacturing Base and Competitors
Table 32. 89bio Inc Major Business
Table 33. 89bio Inc NASH Drug Pipeline Product and Services
Table 34. 89bio Inc NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. ABIONYX Pharma SA Basic Information, Manufacturing Base and Competitors
Table 36. ABIONYX Pharma SA Major Business
Table 37. ABIONYX Pharma SA NASH Drug Pipeline Product and Services
Table 38. ABIONYX Pharma SA NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Abivax SA Basic Information, Manufacturing Base and Competitors
Table 40. Abivax SA Major Business
Table 41. Abivax SA NASH Drug Pipeline Product and Services
Table 42. Abivax SA NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Abliva AB Basic Information, Manufacturing Base and Competitors
Table 44. Abliva AB Major Business
Table 45. Abliva AB NASH Drug Pipeline Product and Services
Table 46. Abliva AB NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Acquist Therapeutics Basic Information, Manufacturing Base and Competitors
Table 48. Acquist Therapeutics Major Business
Table 49. Acquist Therapeutics NASH Drug Pipeline Product and Services
Table 50. Acquist Therapeutics NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. AdAlta Ltd Basic Information, Manufacturing Base and Competitors
Table 52. AdAlta Ltd Major Business
Table 53. AdAlta Ltd NASH Drug Pipeline Product and Services
Table 54. AdAlta Ltd NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Afimmune Biopharma Ltd Basic Information, Manufacturing Base and Competitors
Table 56. Afimmune Biopharma Ltd Major Business
Table 57. Afimmune Biopharma Ltd NASH Drug Pipeline Product and Services
Table 58. Afimmune Biopharma Ltd NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Zhejiang Doer Biologics Corp Basic Information, Manufacturing Base and Competitors
Table 60. Zhejiang Doer Biologics Corp Major Business
Table 61. Zhejiang Doer Biologics Corp NASH Drug Pipeline Product and Services
Table 62. Zhejiang Doer Biologics Corp NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Dicerna Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 64. Dicerna Pharmaceuticals Inc Major Business
Table 65. Dicerna Pharmaceuticals Inc NASH Drug Pipeline Product and Services
Table 66. Dicerna Pharmaceuticals Inc NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. ChemomAb Ltd Basic Information, Manufacturing Base and Competitors
Table 68. ChemomAb Ltd Major Business
Table 69. ChemomAb Ltd NASH Drug Pipeline Product and Services
Table 70. ChemomAb Ltd NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. DURECT Corp Basic Information, Manufacturing Base and Competitors
Table 72. DURECT Corp Major Business
Table 73. DURECT Corp NASH Drug Pipeline Product and Services
Table 74. DURECT Corp NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Eli Lilly and Co Basic Information, Manufacturing Base and Competitors
Table 76. Eli Lilly and Co Major Business
Table 77. Eli Lilly and Co NASH Drug Pipeline Product and Services
Table 78. Eli Lilly and Co NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Enanta Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 80. Enanta Pharmaceuticals Inc Major Business
Table 81. Enanta Pharmaceuticals Inc NASH Drug Pipeline Product and Services
Table 82. Enanta Pharmaceuticals Inc NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. EncuraGen Inc Basic Information, Manufacturing Base and Competitors
Table 84. EncuraGen Inc Major Business
Table 85. EncuraGen Inc NASH Drug Pipeline Product and Services
Table 86. EncuraGen Inc NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Engitix Ltd Basic Information, Manufacturing Base and Competitors
Table 88. Engitix Ltd Major Business
Table 89. Engitix Ltd NASH Drug Pipeline Product and Services
Table 90. Engitix Ltd NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Heprotech Inc Basic Information, Manufacturing Base and Competitors
Table 92. Heprotech Inc Major Business
Table 93. Heprotech Inc NASH Drug Pipeline Product and Services
Table 94. Heprotech Inc NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Hinova Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 96. Hinova Pharmaceuticals Inc Major Business
Table 97. Hinova Pharmaceuticals Inc NASH Drug Pipeline Product and Services
Table 98. Hinova Pharmaceuticals Inc NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. HK inno.N Corp Basic Information, Manufacturing Base and Competitors
Table 100. HK inno.N Corp Major Business
Table 101. HK inno.N Corp NASH Drug Pipeline Product and Services
Table 102. HK inno.N Corp NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. HotSpot Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 104. HotSpot Therapeutics Inc Major Business
Table 105. HotSpot Therapeutics Inc NASH Drug Pipeline Product and Services
Table 106. HotSpot Therapeutics Inc NASH Drug Pipeline Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 107. Global NASH Drug Pipeline Sales by Manufacturer (2019-2021e) & (K Units)
Table 108. Global NASH Drug Pipeline Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 109. Market Position of Manufacturers in NASH Drug Pipeline, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 110. Global NASH Drug Pipeline Production Capacity by Company, (K Units): 2020 VS 2021
Table 111. Head Office and NASH Drug Pipeline Production Site of Key Manufacturer
Table 112. NASH Drug Pipeline New Entrant and Capacity Expansion Plans
Table 113. NASH Drug Pipeline Mergers & Acquisitions in the Past Five Years
Table 114. Global NASH Drug Pipeline Sales by Region (2016-2021e) & (K Units)
Table 115. Global NASH Drug Pipeline Sales by Region (2021-2026) & (K Units)
Table 116. Global NASH Drug Pipeline Revenue by Region (2016-2021e) & (USD Million)
Table 117. Global NASH Drug Pipeline Revenue by Region (2021-2026) & (USD Million)
Table 118. Global NASH Drug Pipeline Sales by Type (2016-2021e) & (K Units)
Table 119. Global NASH Drug Pipeline Sales by Type (2021-2026) & (K Units)
Table 120. Global NASH Drug Pipeline Revenue by Type (2016-2021e) & (USD Million)
Table 121. Global NASH Drug Pipeline Revenue by Type (2021-2026) & (USD Million)
Table 122. Global NASH Drug Pipeline Price by Type (2016-2021e) & (US$/Unit)
Table 123. Global NASH Drug Pipeline Price by Type (2021-2026) & (US$/Unit)
Table 124. Global NASH Drug Pipeline Sales by Application (2016-2021e) & (K Units)
Table 125. Global NASH Drug Pipeline Sales by Application (2021-2026) & (K Units)
Table 126. Global NASH Drug Pipeline Revenue by Application (2016-2021e) & (USD Million)
Table 127. Global NASH Drug Pipeline Revenue by Application (2021-2026) & (USD Million)
Table 128. Global NASH Drug Pipeline Price by Application (2016-2021e) & (US$/Unit)
Table 129. Global NASH Drug Pipeline Price by Application (2021-2026) & (US$/Unit)
Table 130. North America NASH Drug Pipeline Sales by Country (2016-2021e) & (K Units)
Table 131. North America NASH Drug Pipeline Sales by Country (2021-2026) & (K Units)
Table 132. North America NASH Drug Pipeline Revenue by Country (2016-2021e) & (USD Million)
Table 133. North America NASH Drug Pipeline Revenue by Country (2021-2026) & (USD Million)
Table 134. North America NASH Drug Pipeline Sales by Type (2016-2021e) & (K Units)
Table 135. North America NASH Drug Pipeline Sales by Type (2021-2026) & (K Units)
Table 136. North America NASH Drug Pipeline Sales by Application (2016-2021e) & (K Units)
Table 137. North America NASH Drug Pipeline Sales by Application (2021-2026) & (K Units)
Table 138. Europe NASH Drug Pipeline Sales by Country (2016-2021e) & (K Units)
Table 139. Europe NASH Drug Pipeline Sales by Country (2021-2026) & (K Units)
Table 140. Europe NASH Drug Pipeline Revenue by Country (2016-2021e) & (USD Million)
Table 141. Europe NASH Drug Pipeline Revenue by Country (2021-2026) & (USD Million)
Table 142. Europe NASH Drug Pipeline Sales by Type (2016-2021e) & (K Units)
Table 143. Europe NASH Drug Pipeline Sales by Type (2021-2026) & (K Units)
Table 144. Europe NASH Drug Pipeline Sales by Application (2016-2021e) & (K Units)
Table 145. Europe NASH Drug Pipeline Sales by Application (2021-2026) & (K Units)
Table 146. Asia-Pacific NASH Drug Pipeline Sales by Region (2016-2021e) & (K Units)
Table 147. Asia-Pacific NASH Drug Pipeline Sales by Region (2021-2026) & (K Units)
Table 148. Asia-Pacific NASH Drug Pipeline Revenue by Region (2016-2021e) & (USD Million)
Table 149. Asia-Pacific NASH Drug Pipeline Revenue by Region (2021-2026) & (USD Million)
Table 150. Asia-Pacific NASH Drug Pipeline Sales by Type (2016-2021e) & (K Units)
Table 151. Asia-Pacific NASH Drug Pipeline Sales by Type (2021-2026) & (K Units)
Table 152. Asia-Pacific NASH Drug Pipeline Sales by Application (2016-2021e) & (K Units)
Table 153. Asia-Pacific NASH Drug Pipeline Sales by Application (2021-2026) & (K Units)
Table 154. South America NASH Drug Pipeline Sales by Country (2016-2021e) & (K Units)
Table 155. South America NASH Drug Pipeline Sales by Country (2021-2026) & (K Units)
Table 156. South America NASH Drug Pipeline Revenue by Country (2016-2021e) & (USD Million)
Table 157. South America NASH Drug Pipeline Revenue by Country (2021-2026) & (USD Million)
Table 158. South America NASH Drug Pipeline Sales by Type (2016-2021e) & (K Units)
Table 159. South America NASH Drug Pipeline Sales by Type (2021-2026) & (K Units)
Table 160. South America NASH Drug Pipeline Sales by Application (2016-2021e) & (K Units)
Table 161. South America NASH Drug Pipeline Sales by Application (2021-2026) & (K Units)
Table 162. Middle East & Africa NASH Drug Pipeline Sales by Country (2016-2021e) & (K Units)
Table 163. Middle East & Africa NASH Drug Pipeline Sales by Country (2021-2026) & (K Units)
Table 164. Middle East & Africa NASH Drug Pipeline Revenue by Country (2016-2021e) & (USD Million)
Table 165. Middle East & Africa NASH Drug Pipeline Revenue by Country (2021-2026) & (USD Million)
Table 166. Middle East & Africa NASH Drug Pipeline Sales by Type (2016-2021e) & (K Units)
Table 167. Middle East & Africa NASH Drug Pipeline Sales by Type (2021-2026) & (K Units)
Table 168. Middle East & Africa NASH Drug Pipeline Sales by Application (2016-2021e) & (K Units)
Table 169. Middle East & Africa NASH Drug Pipeline Sales by Application (2021-2026) & (K Units)
Table 170. Direct Channel Pros & Cons
Table 171. Indirect Channel Pros & Cons
Table 172. NASH Drug Pipeline Typical Distributors
Table 173. NASH Drug Pipeline Typical Customers
List of Figures
Figure 1. NASH Drug Pipeline Picture
Figure 2. Global NASH Drug Pipeline Sales Market Share by Type in 2020
Figure 3. Protease Inhibitor
Figure 4. Immunomodulatory
Figure 5. Multiple Kinase Inhibitor
Figure 6. Global NASH Drug Pipeline Sales Market Share by Application in 2020
Figure 7. Clinical
Figure 8. Academic Research
Figure 9. Global NASH Drug Pipeline Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global NASH Drug Pipeline Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global NASH Drug Pipeline Sales (2016-2026) & (K Units)
Figure 12. Global NASH Drug Pipeline Price by Type (2016-2026) & (US$/Unit)
Figure 13. Global NASH Drug Pipeline Production Capacity (2016-2026) & (K Units)
Figure 14. Global NASH Drug Pipeline Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. NASH Drug Pipeline Market Drivers
Figure 16. NASH Drug Pipeline Market Restraints
Figure 17. NASH Drug Pipeline Market Trends
Figure 18. Global NASH Drug Pipeline Sales Market Share by Manufacturer in 2020
Figure 19. Global NASH Drug Pipeline Revenue Market Share by Manufacturer in 2020
Figure 20. NASH Drug Pipeline Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 NASH Drug Pipeline Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 NASH Drug Pipeline Manufacturer (Revenue) Market Share in 2020
Figure 23. Global NASH Drug Pipeline Sales Market Share by Region (2016-2026)
Figure 24. Global NASH Drug Pipeline Revenue Market Share by Region (2016-2026)
Figure 25. North America NASH Drug Pipeline Revenue (2016-2026) & (USD Million)
Figure 26. Europe NASH Drug Pipeline Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific NASH Drug Pipeline Revenue (2016-2026) & (USD Million)
Figure 28. South America NASH Drug Pipeline Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa NASH Drug Pipeline Revenue (2016-2026) & (USD Million)
Figure 30. Global NASH Drug Pipeline Sales Market Share by Type (2016-2026)
Figure 31. Global NASH Drug Pipeline Revenue Market Share by Type (2016-2026)
Figure 32. Global NASH Drug Pipeline Price by Type (2016-2026) & (US$/Unit)
Figure 33. Global NASH Drug Pipeline Sales Market Share by Application (2016-2026)
Figure 34. Global NASH Drug Pipeline Revenue Market Share by Application (2016-2026)
Figure 35. Global NASH Drug Pipeline Price by Application (2016-2026) & (US$/Unit)
Figure 36. North America NASH Drug Pipeline Sales Market Share by Type (2016-2026)
Figure 37. North America NASH Drug Pipeline Sales Market Share by Application (2016-2026)
Figure 38. North America NASH Drug Pipeline Sales Market Share by Country (2016-2026)
Figure 39. North America NASH Drug Pipeline Revenue Market Share by Country (2016-2026)
Figure 40. United States NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe NASH Drug Pipeline Sales Market Share by Type (2016-2026)
Figure 44. Europe NASH Drug Pipeline Sales Market Share by Application (2016-2026)
Figure 45. Europe NASH Drug Pipeline Sales Market Share by Country (2016-2026)
Figure 46. Europe NASH Drug Pipeline Revenue Market Share by Country (2016-2026)
Figure 47. Germany NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific NASH Drug Pipeline Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific NASH Drug Pipeline Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific NASH Drug Pipeline Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific NASH Drug Pipeline Revenue Market Share by Region (2016-2026)
Figure 56. China NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America NASH Drug Pipeline Sales Market Share by Type (2016-2026)
Figure 63. South America NASH Drug Pipeline Sales Market Share by Application (2016-2026)
Figure 64. South America NASH Drug Pipeline Sales Market Share by Country (2016-2026)
Figure 65. South America NASH Drug Pipeline Revenue Market Share by Country (2016-2026)
Figure 66. Brazil NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa NASH Drug Pipeline Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa NASH Drug Pipeline Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa NASH Drug Pipeline Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa NASH Drug Pipeline Revenue Market Share by Country (2016-2026)
Figure 72. Turkey NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa NASH Drug Pipeline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source

---